BRCA2 and breast cancer: Several reports suggested that women with germline mutations in BRCA1 are more likely to die from their disease than are women with sporadic breast cancer [3-6], whereas BRCA2 mutation carriers and non-mutation carriers seem to share a similar prognosis [7,8].